PAF1 complex interactions with SETDB1 mediate promoter H3K9 methylation and transcriptional repression of Hoxa9 and Meis1 in acute myeloid leukemia-Reference-Cited by-同舟云学术

PAF1 complex interactions with SETDB1 mediate promoter H3K9 methylation and transcriptional repression of Hoxa9 and Meis1 in acute myeloid leukemia

Published:2018-04-24 Issue:31 Volume:9 Page:22123-22136
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ropa James¹²,Saha Nirmalya¹,Chen Zhiling¹,Serio Justin¹,Chen Wei¹,Mellacheruvu Dattatreya²,Zhao Lili³,Basrur Venkatesha¹,Nesvizhskii Alexey I.¹²,Muntean Andrew G.¹

Affiliation:

1. Department of Pathology and The University of Michigan Medical School, Ann Arbor, Michigan, USA

2. Department of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, Michigan, USA

3. Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SETDB1, an H3K9-specific methyltransferase: An attractive epigenetic target to combat cancer;Drug Discovery Today;2024-05

2. SETDB1: Progress and prospects in cancer treatment potential and inhibitor research;Bioorganic Chemistry;2024-04

3. Cdc73 protects Notch-induced T-cell leukemia cells from DNA damage and mitochondrial stress;Blood;2023-12-21

4. Writers and readers of H3K9me2 form distinct protein networks during the cell cycle that include candidates for H3K9 mimicry;Bioscience Reports;2023-10

5. SETDB1 induces lenalidomide resistance in multiple myeloma cells via epithelial‑mesenchymal transition and PI3K/AKT pathway activation;Experimental and Therapeutic Medicine;2023-04-21